SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Utah Medical Products, Inc. UTMD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Utah Medical Products, Inc. (UTMD) 是一家 Medical - Instruments & Supplies 公司，属于医疗保健行业, 目前交易价格为 $68.80. 其SharesGrow评分为 66/100, 表明高于平均的投资特征， 7项中通过4项.

SharesGrow 的内在价值估计为 UTMD = $106.22 (+54.4% 相对于当前价格, 该股票看起来被低估).

估值: UTMD 市盈率(P/E)为 18.8 (S&P 500平均约25).

财务数据: 营收为 $39M, -9.4%/yr 平均增长. 净利润为 $11M, 增长率为 -11.4%/yr. 净利润率为 29.3% (强劲). 毛利率为 51.6% (-10 pp 趋势).

资产负债表: 总债务为 $225,000 对比 $119M 股东权益 (D/E比率 0, 保守). 流动比率为 37.62 (流动性强). 资产负债率为 0.2%. 总资产: $123M.

SharesGrow 7项标准细分: Value 75/100 (Pass), Growth 15/100 (Fail), Past 100/100 (Pass), Health 100/100 (Pass), Moat 35/100 (Fail), Future ?/100 (Fail), Income 85/100 (Pass).

UTMD SharesGrow 评分概览

68/100

SharesGrow Score

Above average fundamentals

View full scorecard →

价值 75/100

估值 — P/E, PEG, Forward PEG

成长 15/100

财务数据 — 平均增长

过去 100/100

强劲 — 趋势

健康 100/100

资产负债表 — D/E比率, 流动比率为

护城河 35/100

毛利率为 + market cap

未來 0/100

分析师展望 — 为买入

收入 85/100

净利润率为

Scores derived from financial statements, analyst ratings, and balance sheet data.

评分明细 — UTMD

UTMD 市盈率(P/E)为 18.8 (S&P 500平均约25). Forward PEG -7.29 — Peter Lynch 被低估 (≤1.0). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上涨空间 (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

UTMD: -9.4%/yr 营收为, -11.4%/yr 净利润为平均增长. 较弱. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

UTMD: 4 / 4 年盈利. 强劲 — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

资产负债表 UTMD: D/E比率 0 (保守), 流动比率为 37.62 (流动性强). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

UTMD: 毛利率为 51.6% (-10 pp 趋势), N/A market cap. Moat (0-100): margin (35%) + 趋势 (15%) + market cap (30%) + 营收为 (20%). Score 35/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

UTMD: 净利润率为 29.3%. 健康 (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

股票图表与统计

市场数据

52周区间51.26-68.71

成交量12.15K

30日平均成交量15.17K

市值$220.41M

Beta（1年）0.35

股息率$1.2300

股份统计

EPS（TTM）3.41

流通股数$3.31M

IPO日期1999-03-08

员工数155

首席执行官Kevin L. Cornwell

财务亮点与比率

营收（TTM）$38.52M

毛利润$19.88M

EBITDA$17.06M

净利润$11.29M

营业利润$11.4M

现金总额$85.76M

总负债$225K

净负债$-85.53M

总资产$122.54M

市盈率（P/E）20.2

市销率（P/S）5.72

分析师预测

公司信息

国家US

交易所NASDAQ Global Select

货币USD

ISINUS9174881089

股价走势

UTMD

Utah Medical Products, Inc. ↗ · NASDAQ Global Select

Healthcare • Medical - Instruments & Supplies

51.26 52周区间 68.71

其他人也在看

AptarGroup, Inc.

Merit Medical Systems, Inc.

ICU Medical, Inc.

LeMaitre Vascular, Inc.

AngioDynamics, Inc.

InfuSystem Holdings, Inc.

KORU Medical Systems, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言